|
HNRNPA0 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.120400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.515000E-01 |
| Normal-vs-Stage2 |
7.018400E-01 |
| Normal-vs-Stage3 |
1.837000E-01 |
| Normal-vs-Stage4 |
3.877000E-01 |
| Stage1-vs-Stage2 |
7.766600E-01 |
| Stage1-vs-Stage3 |
6.543600E-01 |
| Stage1-vs-Stage4 |
9.101000E-01 |
| Stage2-vs-Stage3 |
5.756600E-01 |
| Stage2-vs-Stage4 |
8.414400E-01 |
| Stage3-vs-Stage4 |
6.397800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.691400E-01 |
| Normal-vs-AfricanAmerican |
5.037000E-01 |
| Normal-vs-Asian |
1.912960E-01 |
| Caucasian-vs-AfricanAmerican |
1.670350E-01 |
| Caucasian-vs-Asian |
5.880200E-01 |
| AfricanAmerican-vs-Asian |
1.463400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.858000E-01 |
| Normal-vs-Female |
8.694000E-02 |
| Male-vs-Female |
4.199900E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.875200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.431600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.469980E-01 |
| Normal-vs-Age(81-100Yrs) |
7.728800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.856400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.199800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.742400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.184800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.254800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.458600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.604000E-03 |
| Classical-VS-Follicular |
2.856100E-03 |
| Classical-VS-Other |
7.181000E-01 |
| Classical-VS-Normal |
8.780000E-01 |
| Tall-VS-Follicular |
7.318800E-01 |
| Tall-VS-Other |
3.083600E-01 |
| Tall-VS-Normal |
1.308160E-02 |
| Follicular-VS-Other |
5.024000E-01 |
| Follicular-VS-Normal |
1.824030E-02 |
| Other-VS-Normal |
7.387200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.322200E-02 |
| Normal-vs-N1 |
3.511200E-01 |
| N0-vs-N1 |
5.988200E-01 |
|
|
